Amit Parhar
Building AI-ready Multi-omics Data Lakes for Biomarker Discovery
Modern drug development generates staggering volumes of molecular data. Genomic ...
How GenAI Is Changing Translational Research and Why It Matters Now
Translational research sits at the critical junction between laboratory discovery and ...
Women’s Health Is Still Underserved by Modern Diagnostics and AI Can Help Change That!
Women’s health month should be more than a visibility moment. It should compel leaders to ...
Building a CAP/CLIA-compliant NGS pipeline: A Technical Blueprint for Diagnostic Labs
In clinical genomics, the labs that scale fastest are not necessarily the ones with the ...
Multi-omics Explained: How Integrating Genomics, Proteomics, and Metabolomics Transforms Disease Understanding
When a cancer cell escapes therapy, it rarely relies on one rogue mutation. It rewires ...
What Is cfDNA? A Beginner’s Guide to Liquid Biopsy and Cell-free DNA Analysis
Imagine diagnosing cancer with a routine blood draw — no surgery, no tissue biopsy, and ...
How Multi-omics, AI, and Real-world Evidence Are Accelerating Biomarker Discovery
"The right biomarker doesn’t just describe disease – it determines destiny." More data ...
Designing Patient-centric Rare-disease Trials with AI, Digital Health, and Multi-omics
Peter Drucker, the renowned Austrian-American consultant and educator, famously said, ...
From Sequencer to Tumor Board: How AI-powered Genomics Platforms Are Rewriting Cancer Diagnosis and Treatment
Cancer care is undergoing a profound shift. What once took weeks of manual interpretation ...
Audit-ready, Cloud-native NGS Pipelines: Ending the Rare Disease Diagnostic Odyssey with Reproducible Science
Did you know that an average rare disease patient spends nearly five years searching for ...
AI-powered Germline Variant Interpretation: Transforming Rare Disease Diagnosis in the Era of Precision Medicine
For rare-disease patients, the diagnostic journey often stretches beyond six years and ...
How NGS and Machine Learning Are Driving 90%+ Diagnostic Performance in Lung Cancer
Global and national epidemiology shows lung cancer remains the leading cause of cancer ...
From Silos to Seamless: How API-first Ecosystems Are Redefining Genomics & Healthcare IT
The success metrics for genomics and healthcare IT projects have undergone significant ...
Reimagining Rare Disease Diagnosis with GenAI: ClairLabs’ Vision for the Future of Precision Medicine
Rare diseases account for nearly 5% of the global disease burden. With the advent of ...
